Generali Investments Management Co LLC Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Generali Investments Management Co LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,894 shares of the medical equipment provider's stock after selling 1,076 shares during the quarter. Intuitive Surgical comprises 1.1% of Generali Investments Management Co LLC's portfolio, making the stock its 20th largest position. Generali Investments Management Co LLC's holdings in Intuitive Surgical were worth $3,910,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical in the fourth quarter worth approximately $26,000. Global Financial Private Client LLC raised its position in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the period. BankPlus Trust Department bought a new position in Intuitive Surgical in the fourth quarter worth approximately $28,000. Finally, Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Down 0.2%

Shares of NASDAQ ISRG traded down $0.98 during trading hours on Friday, hitting $557.08. 1,103,774 shares of the stock were exchanged, compared to its average volume of 1,641,815. The company has a market cap of $199.67 billion, a PE ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67. The firm has a fifty day moving average price of $521.99 and a 200-day moving average price of $539.26. Intuitive Surgical, Inc. has a 12 month low of $413.52 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the business posted $1.50 EPS. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

ISRG has been the topic of several recent analyst reports. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday. Royal Bank of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Finally, Citigroup reiterated a "buy" rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $596.05.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president now directly owns 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. This trade represents a 60.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 25,443 shares of company stock worth $12,692,195. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.